ELATIVE
Live / Registered — Registered (as of 27 Sept 2022)
What this means for you
Registered since 27 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79324525
- Registration number
- 6854744
- Mark type
- Design + words
- Filed
- 25 Jun 2021
- Published for opposition
- 12 Jul 2022
- Registered
- 27 Sept 2022
- Attorney of record
- Ronald M. Kachmarik
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of liver diseases, cholesterol diseases, metabolic diseases, gastroenterological diseases, inflammatory diseases, auto-immune diseases and cancer diseases; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholesterol diseases, metabolic diseases , gastroenterological diseases, inflammatory diseases, auto-immune diseases and cancer diseases; organic biological preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholesterol diseases, metabolic diseases , gastroenterological diseases, inflammatory diseases, auto-immune diseases and cancer diseases; diagnostic preparations for medical use; diagnostic reagents for medical use
- Class 042 — Scientific and technological services: Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical products, in particular conducting clinical trials for others for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely providing information, results and data relating to scientific or medical research and development of pharmaceutical products, especially from an online searchable database; medical and scientific research, namely conducting clinical trials for others; pharmaceutical and biological development and research services for third parties; clinical research for others in the field of pharmaceuticals and medicines; evaluation of the efficacy of pharmaceutical products
Owner
Prosecution history
- 19 Jun 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 14 Feb 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 25 Jan 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 25 Jan 2023 — FINAL DISPOSITION PROCESSED
- 27 Dec 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 27 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 19 Jul 2022 — NOTIFICATION PROCESSED BY IB
- 12 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Jul 2022 — PUBLISHED FOR OPPOSITION
- 29 Jun 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Jun 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 22 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jun 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED